XXEC Inc. Makes New $77.04 Million Investment in Mettler-Toledo International, Inc. $MTD

XXEC Inc. bought a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 88,831,888 shares of the medical instruments supplier’s stock, valued at approximately $77,044,000. Mettler-Toledo International accounts for approximately 0.0% of XXEC Inc.’s investment portfolio, making the stock its 22nd largest holding. XXEC Inc. owned 4.43% of Mettler-Toledo International as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of MTD. Whipplewood Advisors LLC bought a new stake in shares of Mettler-Toledo International during the first quarter worth approximately $25,000. Reflection Asset Management bought a new position in Mettler-Toledo International in the fourth quarter valued at approximately $26,000. Edmond DE Rothschild Holding S.A. bought a new position in Mettler-Toledo International in the second quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new stake in Mettler-Toledo International during the 4th quarter worth $29,000. Finally, Root Financial Partners LLC grew its holdings in Mettler-Toledo International by 45.5% during the 1st quarter. Root Financial Partners LLC now owns 32 shares of the medical instruments supplier’s stock worth $40,000 after acquiring an additional 10 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Up 0.0%

Shares of NYSE:MTD opened at $1,393.43 on Friday. The company has a 50 day moving average price of $1,319.66 and a two-hundred day moving average price of $1,274.32. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. The company has a market capitalization of $27.92 billion, a PE ratio of 31.36, a PEG ratio of 2.87 and a beta of 1.23. Mettler-Toledo International, Inc. has a 52 week low of $1,023.05 and a 52 week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping analysts’ consensus estimates of $10.78 by $0.68. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period last year, the firm posted $10.09 earnings per share. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Analysts forecast that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Thomas P. Salice sold 417 shares of the firm’s stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $1,440.41, for a total transaction of $600,650.97. Following the sale, the director owned 292 shares of the company’s stock, valued at approximately $420,599.72. This trade represents a 58.82% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Shawn Vadala sold 2,240 shares of Mettler-Toledo International stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total value of $3,207,680.00. Following the transaction, the chief financial officer owned 5,579 shares in the company, valued at approximately $7,989,128. This represents a 28.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 3,312 shares of company stock valued at $4,750,362. 0.71% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Jefferies Financial Group increased their price target on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Wolfe Research started coverage on Mettler-Toledo International in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. Wells Fargo & Company upped their price objective on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Citigroup cut their target price on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Finally, Wall Street Zen cut Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $1,461.27.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.